We are live on ! Find out more
OGEN icon

Oragenics
OGEN

12 hedge funds and large institutions have $7.21M invested in Oragenics in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

16% less capital invested

Capital invested by funds: $8.63M → $7.21M (-$1.42M)

25% less funds holding

Funds holding: 16 → 12 (-4)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
12
Holders Change
-4
Holders Change %
-25%
% of All Funds
0.3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
2
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
+$51.9K
2
Citadel Advisors
Citadel Advisors
Florida
+$7.41K

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$41K
2
BCM
Bridgeway Capital Management
Texas
-$37.1K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$37.1K
4
PPA
Parametric Portfolio Associates
Washington
-$13K
5
UBS Group
UBS Group
Switzerland
-$7.41K
Name Holding Trade Value Shares
Change 		Change in
Stake
TS
1
Third Security
Virginia
$5.73M – – –
MP
2
MSD Partners
New York
$638K – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$617K – – –
VKH
4
Virtu KCG Holdings
New York
$57K +$51.9K +7 +350%
Vanguard Group
5
Vanguard Group
Pennsylvania
$39K -$37.1K -5 -45%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$33K – – –
BCM
7
Bridgeway Capital Management
Texas
$18K -$37.1K -5 -63%
Citadel Advisors
8
Citadel Advisors
Florida
$18K +$7.41K +1 +50%
Goldman Sachs
9
Goldman Sachs
New York
$14K – – –
IA
10
IFP Advisors
Florida
$11K – – –
Northern Trust
11
Northern Trust
Illinois
$11K – – –
GC
12
Guggenheim Capital
Illinois
$7K – – –
HWM
13
Holloway Wealth Management
Florida
$5K – – –
UBS Group
14
UBS Group
Switzerland
$3K -$7.41K -1 Closed
BlackRock
15
BlackRock
New York
$3K – – –
Manulife (Manufacturers Life Insurance)
16
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K – – –
Bank of America
17
Bank of America
North Carolina
$1K – – –
Wells Fargo
18
Wells Fargo
California
– -$41K -5 Closed
PPA
19
Parametric Portfolio Associates
Washington
– -$13K -2 Closed
BIP
20
Brandes Investment Partners
California
– -$6K -1 Closed

OGEN Hedge Fund Activity: Q2 2017 in Review

12 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q2 2017, worth a combined $7.21M — down 16% from $8.63M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of OGEN and 0 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Virtu KCG Holdings, adding an estimated $51.9K. The largest seller was Wells Fargo, exiting entirely with an estimated $41K sold.

  • 12 institutional investors held Oragenics (OGEN) as of Q2 2017, down from 16 in Q1 2017.
  • Funds reported $7.21M of Oragenics stock for Q2 2017, down 16% quarter-over-quarter.
  • 0 funds opened new Oragenics positions in Q2 2017 and 4 closed out, a net change of -4 holders.
  • The largest Oragenics buyer in Q2 2017 was Virtu KCG Holdings, an estimated $51.9K added.
  • The largest Oragenics seller in Q2 2017 was Wells Fargo, an estimated $41K sold.

Based on aggregated 13F filings for Q2 2017.